Profund Advisors LLC Intra Cellular Therapies, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 6,033 shares of ITCI stock, worth $501,402. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,033

Previous 6,678 9.66%

Holding current value

$501,402

Previous $457,000 3.5%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$67.99 - $80.84 $43,853 - $52,141	-645 Reduced 9.66%	6,033 $441,000
Q2 2024 Aug 13, 2024	SELL	$64.76 - $79.84 $284,684 - $350,976	-4,396 Reduced 39.7%	6,678 $457,000
Q1 2024 May 08, 2024	BUY	$64.37 - $75.65 $8,174 - $9,607	127 Added 1.16%	11,074 $766,000
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $54,948 - $87,275	-1,185 Reduced 9.77%	10,947 $784,000
Q3 2023 Nov 13, 2023	BUY	$52.09 - $64.1 $59,122 - $72,753	1,135 Added 10.32%	12,132 $631,000
Q2 2023 Aug 10, 2023	SELL	$54.67 - $66.44 $14,815 - $18,005	-271 Reduced 2.41%	10,997 $696,000
Q1 2023 May 11, 2023	BUY	$43.8 - $56.99 $134,247 - $174,674	3,065 Added 37.36%	11,268 $610,000
Q4 2022 Feb 02, 2023	BUY	$44.07 - $54.45 $21,682 - $26,789	492 Added 6.38%	8,203 $434,000
Q3 2022 Nov 04, 2022	SELL	$42.7 - $59.99 $555 - $779	-13 Reduced 0.17%	7,711 $359,000
Q2 2022 Aug 01, 2022	BUY	$43.0 - $65.64 $8,170 - $12,471	190 Added 2.52%	7,724 $441,000
Q1 2022 May 10, 2022	BUY	$38.74 - $62.09 $19,137 - $30,672	494 Added 7.02%	7,534 $461,000
Q4 2021 Feb 08, 2022	BUY	$35.2 - $53.42 $9,961 - $15,117	283 Added 4.19%	7,040 $368,000
Q3 2021 Nov 12, 2021	SELL	$28.72 - $42.49 $16,198 - $23,964	-564 Reduced 7.7%	6,757 $252,000
Q2 2021 Aug 12, 2021	BUY	$29.3 - $44.5 $18,810 - $28,569	642 Added 9.61%	7,321 $298,000
Q1 2021 May 14, 2021	BUY	$30.8 - $39.51 $205,713 - $263,887	6,679 New	6,679 $227,000
Q1 2019 May 15, 2019	SELL	$10.9 - $14.09 $131,715 - $170,263	-12,084 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $28,956 - $58,583	-2,795 Reduced 18.78%	12,084 $138,000
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $264,399 - $340,729	14,879 New	14,879 $323,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Intra Cellular Therapies, Inc. Transaction History